Art

J-GLOBAL ID：201102264085754146   Reference number：11A1109956

Potential Benefit of Statin Therapy for Dyslipidemia with Chronic Kidney Disease: Fluvastatin Renal Evaluation Trial (FRET)

慢性腎臓病を伴う脂質異常症に対するスタチン療法の潜在的利益:Fluvastatin Renal Evaluation Trial(FRET)

Author (11)： INOUE Teruo (Dep. of Cardiovascular Medicine, Dokkyo Medical Univ., JPN) ,  IKEDA Hideo (Saga Medical Assoc., JPN) ,  NAKAMURA Tsukasa (Dep. of Internal Medicine, Shinmatsudo Central General Hospital, JPN) ,  ABE Shichiro (Dep. of Cardiovascular Medicine, Dokkyo Medical Univ., JPN) ,  TAGUCHI Isao (Dep. of Cardiovascular Medicine, Dokkyo Medical Univ., JPN) ,  KIKUCHI Migaku (Dep. of Cardiovascular Medicine, Dokkyo Medical Univ., JPN) ,  TOYODA Shigeru (Dep. of Cardiovascular Medicine, Dokkyo Medical Univ., JPN) ,  MIYAZONO Motoaki (Dep. of Cardiovascular & Renal Medicine, Saga Univ., JPN) ,  KISHI Tomoya (Dep. of Cardiovascular & Renal Medicine, Saga Univ., JPN) ,  SANAI Toru (Dep. of Cardiovascular & Renal Medicine, Saga Univ., JPN) ,  NODE Koichi (Dep. of Cardiovascular & Renal Medicine, Saga Univ., JPN)
Material： Internal Medicine (Web)  (Intern Med (Web))
Volume： 50  Issue： 12  Page： 1273-1278 (J-STAGE)  Publication year： 2011 
JST Material Number： U0033A  ISSN： 1349-7235  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： FRET試験 ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=11A1109956&from=J-GLOBAL&jstjournalNo=U0033A") }}

JST classification (3)： Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of drugs acting on lipid metabolism  (GW13050X) ,  Drug therapy(=pharmacotherapy)for urogenital diseases  (GM05020V)

Substance index (2)： 8-Hydroxy-2'-deoxyguanosine ,  Fluvastatin

Reference (20)：

• 1. Parikh NI, Hwang SJ, Larson MG, Meigs JB, Levy D, Fox CS. Cardiovascular disease risk factors in chronic kidney disease: overall burden and rates of treatment and control. Arch Intern Med 166: 1884-1891, 2006.
• 2. Schaeffner ES, Kurth T, Curhan GC, et al. Cholesterol and the risk of renal dysfunction in apparently healthy men. J Am Soc Nephrol 14: 2084-2091, 2003.
• 3. Chan CM. Hyperlipidemia in chronic kidney disease. Ann Acad Med Singapore 34: 31-35, 2005.
• 4. Sandhu S, Wiebe N, Fried LF, Tonelli M. Statins for improving renal outcomes: a meta-analysis. J Am Soc Nephrol 17: 2006-2016, 2006.
• 5. Suzumura K, Yasuhara M, Narita H. Superoxide anion scavenging properties of fluvastatin and its metabolites. Chem Pharm Bull 47: 1477-1480, 1994.

Terms in the title (5)： 慢性腎臓病 ,  脂質異常症 ,  スタチン療法 ,  利益 ,  FRET